EXV7:XETRA:XETRA-iShares STOXX Europe 600 Chemicals UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 132.9

Change

-1.38 (-1.03)%

Market Cap

USD 0.09B

Volume

401.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B

ETFs Containing EXV7:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.60% 34% F 39% F
Dividend Return 0.09% 4% F 2% F
Total Return 3.69% 34% F 38% F
Trailing 12 Months  
Capital Gain 16.11% 50% F 54% F
Dividend Return 0.67% 16% F 11% F
Total Return 16.78% 52% F 54% F
Trailing 5 Years  
Capital Gain 46.54% 61% D- 64% D
Dividend Return 5.60% 62% D 33% F
Total Return 52.14% 66% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 7.61% N/A N/A 60% D-
Dividend Return 8.63% N/A N/A 62% D
Total Return 1.03% N/A N/A 46% F
Risk Return Profile  
Volatility (Standard Deviation) 13.86% N/A N/A 53% F
Risk Adjusted Return 62.29% N/A N/A 67% D+
Market Capitalization 0.09B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.